NI201200073A - CYCLIC CARBOXYL ACID DERIVATIVES SUBSTITUTED WITH ACILAMINE AND THEIR USE AS A PHARMACEUTICAL PRODUCT - Google Patents

CYCLIC CARBOXYL ACID DERIVATIVES SUBSTITUTED WITH ACILAMINE AND THEIR USE AS A PHARMACEUTICAL PRODUCT

Info

Publication number
NI201200073A
NI201200073A NI201200073A NI201200073A NI201200073A NI 201200073 A NI201200073 A NI 201200073A NI 201200073 A NI201200073 A NI 201200073A NI 201200073 A NI201200073 A NI 201200073A NI 201200073 A NI201200073 A NI 201200073A
Authority
NI
Nicaragua
Prior art keywords
acilamine
acid derivatives
pharmaceutical product
carboxyl acid
compounds
Prior art date
Application number
NI201200073A
Other languages
Spanish (es)
Inventor
Kleeman Heinz-Werner
Pernerstorfer Josef
Schaefer Matthias
Safarova Alena
Patek Marcel
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of NI201200073A publication Critical patent/NI201200073A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención se refiere a compuestos de la fórmula I, en la que A, Y, Z, R20 a R22 y R50 tienen los significados indicados en las reivindicaciones, que son compuestos farmacéuticos activos valiosos. Específicamente, son inhibidores del receptor del gen de diferenciación endotelial 2 ( Edg-2, EDG2), que se activa por el ácido lisofosfatídico (LPA) y también se denomina receptor LPA1, y son útiles para el tratamiento de enfermedades tales como aterosclerosis, infarto de miocardio e insuficiencia cardiaca, por ejemplo. La invención se refiere además a procedimientos para preparar los compuestos de la fórmula I, a su uso y a composiciones farmacéuticas que los comprenden.The present invention relates to compounds of formula I, in which A, Y, Z, R20 to R22 and R50 have the meanings indicated in the claims, which are valuable active pharmaceutical compounds. Specifically, they are inhibitors of the receptor for endothelial differentiation gene 2 (Edg-2, EDG2), which is activated by lysophosphatidic acid (LPA) and is also called LPA1 receptor, and they are useful for the treatment of diseases such as atherosclerosis, heart attack. of myocardium and heart failure, for example. The invention further relates to processes for preparing the compounds of formula I, their use and pharmaceutical compositions comprising them.

NI201200073A 2009-11-02 2012-04-27 CYCLIC CARBOXYL ACID DERIVATIVES SUBSTITUTED WITH ACILAMINE AND THEIR USE AS A PHARMACEUTICAL PRODUCT NI201200073A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09290831 2009-11-02
US31961910P 2010-03-31 2010-03-31

Publications (1)

Publication Number Publication Date
NI201200073A true NI201200073A (en) 2012-10-29

Family

ID=69650461

Family Applications (1)

Application Number Title Priority Date Filing Date
NI201200073A NI201200073A (en) 2009-11-02 2012-04-27 CYCLIC CARBOXYL ACID DERIVATIVES SUBSTITUTED WITH ACILAMINE AND THEIR USE AS A PHARMACEUTICAL PRODUCT

Country Status (2)

Country Link
CL (1) CL2012001142A1 (en)
NI (1) NI201200073A (en)

Also Published As

Publication number Publication date
CL2012001142A1 (en) 2012-08-31

Similar Documents

Publication Publication Date Title
ECSP12011861A (en) DERIVATIVES OF CYCLIC CARBOXYLIC ACID SUBSTITUTED WITH ACILAMINE AND ITS USE AS PHARMACEUTICAL PRODUCTS
CO6300933A2 (en) CONDENSED CYCLOPENTANOCARBOXYLIC ACID DERIVATIVES SUBSTITUTED WITH ACILAMINE AND ITS USE AS PHARMACEUTICAL PRODUCTS
BR112012023421A2 (en) pharmaceutical composition for intraocular pressure increase treatment
EA201171066A1 (en) NEW SUBSTITUTED DERIVATIVES OF BENZOXIAZOLE, BENZIMIDAZOLE, OXAZOZOLOPIRIDINE AND IMIDAZOPIRIDINE AS GAMMA SECRETIS MODULATORS
CO6351778A2 (en) NAFTILACETIC ACIDS
CO7310531A2 (en) 4-methyl-2,3,8,9,9b-pentaaza-cyclopenta [a] naphthalenes
UY35156A (en) DERIVATIVES OF ACETIC INDANILOXI DIHIDROBENZOFURANIL ACID AS AGONISTS OF THE GPR40
CO6761373A2 (en) Substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceutical substances
ECSP13012494A (en) OXADIAZOL INHIBITORS OF LEUCOTRENE PRODUCTION.
BR112013004662B8 (en) Compound, pharmaceutical composition, uses of a compound, and method of preparing a pharmaceutical composition
UA109867C2 (en) Substituted pyrazole compounds as antagonists lysophosphatidic acid receptors (lpar)
BR112013030391A2 (en) 3-spirocyclic piperidine derivatives as ghrelin receptor agonists
NI201200073A (en) CYCLIC CARBOXYL ACID DERIVATIVES SUBSTITUTED WITH ACILAMINE AND THEIR USE AS A PHARMACEUTICAL PRODUCT
MX2013003736A (en) Novel gpr 119 agonists.
NI201000182A (en) DERIVATIVES OF CONDENSED CYCLOPENTANOCARBOXYLIC ACID REPLACED WITH ACILAMINE AND THEIR USE AS PHARMACEUTICAL PRODUCTS.
IN2014MN02433A (en)
DOP2013000182A (en) CATEPSIN C INHIBITORS
UY29550A1 (en) DERIVATIVES OF (SULFAMOIL-ALQUIL) -AMIDE OF HETEROARIL-CARBOXYL ACID AS INHIBITORS OF THE XA FACTOR
PA8825401A1 (en) SYSTEMS AND METHODS TO SELECT FLOUR
TN2010000466A1 (en) Acylamino subsitutued fused cyclopentanecarboxylic acid derivatives and their use as pharmaceuticals
CU20100214A7 (en) IMIDAZOQUINOLINAS AS LIPID KINASE INHIBITORS
CU20100173A7 (en) INDAZOL DERIVATIVES